NUVL
Nuvalent Inc-A
NASDAQ · Biotechnology
$103.59
+2.69 (+2.67%)
Performance
1D
—
1W
-1.30%
1M
+4.47%
3M
+7.73%
6M
+32.40%
1Y
+24.30%
YTD
+2.73%
Open$102.21
Previous Close$100.90
Day High$104.40
Day Low$101.12
52W High$113.02
52W Low$55.54
Volume566.5K
Avg Volume525.3K
Market Cap7.53B
P/E Ratio—
EPS$-5.32
SectorBiotechnology
Volume Analysis
1.08x average volume
Technical Indicators
SMA 50
$104.64
Below
SMA 200
$87.48
Above
RSI (14)
49.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
-67.9% upside
Current
$103.59
$103.59
Target
$33.28
$33.28
$20.12
$33.28 avg
$44.46
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.56B | 1.45B | 1.21B |
| Net Income | -302,764,100 | -377,638,036 | -264,320,064 |
| Profit Margin | -19.4% | -26.0% | -21.8% |
| EBITDA | -533,448,597 | -500,050,490 | -459,692,337 |
| Free Cash Flow | -391,442,676 | -279,670,611 | -274,115,194 |
| Rev Growth | +10.6% | +5.5% | +20.0% |
| Debt/Equity | 0.68 | 0.65 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |